Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Genetics ; 157(2): 579-89, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11156980

RESUMO

DNA double-strand breaks (DSBs) are repaired by homologous recombination (HR) and nonhomologous end-joining (NHEJ). NHEJ in yeast chromosomes has been observed only when HR is blocked, as in rad52 mutants or in the absence of a homologous repair template. We detected yKu70p-dependent imprecise NHEJ at a frequency of approximately 0.1% in HR-competent Rad+ haploid cells. Interestingly, yku70 mutation increased DSB-induced HR between direct repeats by 1.3-fold in a haploid strain and by 1.5-fold in a MAT homozygous (a/a) diploid, but yku70 had no effect on HR in a MAT heterozygous (a/alpha) diploid. yku70 might increase HR because it eliminates the competing precise NHEJ (religation) pathway and/or because yKu70p interferes directly or indirectly with HR. Despite the yku70-dependent increase in a/a cells, HR remained 2-fold lower than in a/alpha cells. Cell survival was also lower in a/a cells and correlated with the reduction in HR. These results indicate that MAT heterozygosity enhances DSB-induced HR by yKu-dependent and -independent mechanisms, with the latter mechanism promoting cell survival. Surprisingly, yku70 strains survived a DSB slightly better than wild type. We propose that this reflects enhanced HR, not by elimination of precise NHEJ since this pathway produces viable products, but by elimination of yKu-dependent interference of HR.


Assuntos
Antígenos Nucleares , Dano ao DNA/genética , DNA Helicases , Proteínas de Ligação a DNA/genética , Heterozigoto , Proteínas Nucleares/genética , Peptídeos/genética , Recombinação Genética/genética , Proteínas de Saccharomyces cerevisiae , Alelos , Divisão Celular , Reparo do DNA , Diploide , Haploidia , Autoantígeno Ku , Fator de Acasalamento , Modelos Genéticos , Mutação , Plasmídeos/metabolismo , Ligação Proteica
2.
Carcinogenesis ; 18(6): 1177-82, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9214600

RESUMO

Previous studies have shown that polycyclic aromatic hydrocarbons (PAHs) mobilize intracellular Ca2+ in human T cells by inositol trisphosphate-dependent mechanisms resulting from activation of phospholipase C-gamma by SRC-related protein tyrosine kinases, thereby mimicking antigen-receptor activation. Ca2+ appears to play an important second messenger role in growth factor control of cell proliferation in human mammary epithelial cells (HMEC), such as the epidermal growth factor receptor pathway. The purpose of the present studies was to determine if PAHs are able to increase intracellular Ca2+ in primary cultures of HMEC and increase cell proliferation. Two carcinogenic and two non-carcinogenic PAHs were tested for their ability to increase intracellular Ca2+ in HMEC. The carcinogenic PAHs dimethylbenz[a]anthracene (DMBA) and benzo[a] pyrene (BaP) were able to cause Ca2+ elevation in HMEC at early time points (2 h) and caused sustained alterations in Ca2+ homeostasis (18 h). DMBA showed maximal effects at early time points (2 h), while BaP showed maximal effects on sustained Ca2+ (18 h). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a potent dioxin and tumor promoter, produced maximal Ca2+ elevation at 2 h, with a return to near baseline levels by 6 h. The non-carcinogenic PAHs benzo[e]pyrene and anthracene did not significantly alter intracellular Ca2+ at any time point. alpha-Naphthoflavone significantly reduced the Ca2+ response induced by BaP treatment, but not by DMBA or TCDD, suggesting that P450 1A or 1B metabolism of BaP may be important in the sustained Ca2+ elevating response. In evaluating the effects of BaP on HMEC proliferation, BaP was found to increase the number of cells recovered after 4 days in culture in the absence or presence of various concentrations of epidermal growth factor. These studies provide initial evidence that Ca2+ signaling may be associated with mitogenesis in HMEC, which may play a role in tumor promotion and progression produced by PAHs.


Assuntos
Mama/efeitos dos fármacos , Mama/metabolismo , Cálcio/metabolismo , Carcinógenos/farmacologia , Hidrocarbonetos Policíclicos Aromáticos/farmacologia , 9,10-Dimetil-1,2-benzantraceno/farmacologia , Benzo(a)pireno/farmacologia , Benzoflavonas/farmacologia , Mama/citologia , Neoplasias da Mama/induzido quimicamente , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Transformação Celular Neoplásica , Células Cultivadas , Epitélio/efeitos dos fármacos , Epitélio/metabolismo , Feminino , Homeostase/efeitos dos fármacos , Humanos , Líquido Intracelular/metabolismo , Dibenzodioxinas Policloradas/farmacologia
3.
Kidney Int ; 50(3): 1044-50, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8872982

RESUMO

Rates of secretion of granulocyte-macrophage colony stimulating factor (GM-CSF) were measured in 50 primary cell cultures derived from cancerous and normal human kidneys. Mean rates of GM-CSF secretion measured by TF-1 cell proliferation assay (N = 21) and by ELISA (N = 31) were 2.5 and 7.8 ng/10(6) cells/24 hr, respectively. There was no significant difference between the mean rates of GM-CSF secretion by cancerous and normal renal cells. GM-CSF was also secreted by primary renal cell cultures grown in serum-free medium and by renal cell lines. GM-CSF mRNA was detected by RT-PCR in cultured renal cells, but not in undissociated kidney tissue. Rates of GM-CSF secretion were reduced up to 99% under conditions where the cellular density or substratum more closely resembled the in vivo environment. Some cultured human renal carcinoma cells (RCC) secreted GM-CSF at levels that occasionally overlapped the levels produced by the GM-CSF gene-modified human RCC vaccine now in phase I trial. The data indicate that GM-CSF is not expressed in vivo, and that stable GM-CSF secretion is induced by the dissociation and culture of human renal cells.


Assuntos
Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Rim/citologia , Adenocarcinoma , Carcinoma de Células Renais , Contagem de Células , Linhagem Celular/citologia , Linhagem Celular/metabolismo , Linhagem Celular/fisiologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/genética , Humanos , Interleucina-1/metabolismo , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/fisiologia
4.
Fundam Appl Toxicol ; 21(1): 120-4, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8365579

RESUMO

The mechanism by which 7,12-dimethylbenz[a]anthracene (DMBA) produces cytotoxicity in lymphocytes was investigated in these studies using the murine A20.1 B cell lymphoma. Results show that in vitro exposure of these cells to 10-30 microM DMBA for 4 hr produced an increase in intracellular Ca2+, DNA fragmentation, and subsequent cell death. Elevation of Ca2+ and DNA fragmentation induced by DMBA were greatly pronounced when the A20.1 cells were exposed at high cell density (10(7) cells/ml). DMBA-induced DNA fragmentation and cell death were inhibited by coexposure of A20.1 cells to a calcium chelator (EDTA), a general nuclease and polymerase inhibitor (aurintricarboxylic acid), and a protein synthesis inhibitor (cycloheximide). These agents have been previously shown to inhibit apoptosis in lymphocytes and other cells exposed to chemical agents. We also found that cyclosporin A, an inhibitor of Ca(2+)-dependent pathways of T and B cell activation, prevented apoptosis in the A20.1 cell line. These results demonstrate that DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma by Ca(2+)-dependent pathways. The increased sensitivity of A20.1 at high cell density to Ca2+ elevation and DNA fragmentation suggests that cell to cell interactions may also be important in this process.


Assuntos
9,10-Dimetil-1,2-benzantraceno/toxicidade , Apoptose/efeitos dos fármacos , Linfócitos B/efeitos dos fármacos , Animais , Divisão Celular/efeitos dos fármacos , DNA de Neoplasias/efeitos dos fármacos , Linfoma de Células B , Camundongos , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA